BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Silk Therapeutics Appoints Dr. Rebecca Lacouture to Company President

  In this expanded role, Lacouture will drive growth of the company’s sustainable process for large-scale production of natural silk in liquid form, while maintaining her position as COO and a member of the board of directors.

  December 14, 2017

   · 

  3 min read
• Business

  SIRC Announces Leadership Changes

  Executive Director John O. “Jack” Snyder is retiring after more than 24 years with the organization.

  December 14, 2017

   · 

  3 min read
• 

  FDA

  Chemence Medical Scores FDA Clearance for Exofin Fusion Skin Closure System

  Exofin Fusion is a a new skin closure system to treat medium to large wounds.

  December 14, 2017

   · 

  2 min read
• Biotech Beach

  Two Innovus Pharma Products Officially Listed in OTC Section of the RED BOOK

  Innovus Pharma announced that two of its flagship products, FlutiCare for nasal allergy relief and UriVarx for bladder health, have been approved for listing in the RED BOOK pharmacy pricing database

  December 14, 2017

   · 

  5 min read
• Biotech Bay

  HeartFlow Announces Decision by HCSC and Additional BlueCross BlueShield Companies to Issue New Positive Medical Policies for Non-Invasive HeartFlow FFRct Analysis

  Beginning January 1, 2018, hospitals that are enrolled in Medicare and bill CMS will be able to submit claims for the HeartFlow FFRct Analysis for Medicare patients.

  December 14, 2017

   · 

  5 min read
• Kitov Announces Consensi as Brand Name for KIT-302

  Kitov Pharma announced today that the FDA has granted permission to Kitov to use the brand name Consensi for marketing KIT-302, subject to receipt of marketing approval from the FDA.

  December 14, 2017

   · 

  5 min read
• Business

  Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member

  TSI today announced the appointment of Annalisa Jenkins, MBBS, FRCP, formerly President and CEO of Dimension Therapeutics, as a non-executive board member.

  December 14, 2017

   · 

  2 min read
• Genetown

  IDBS Adds Synthetic Chemistry to its E-WorkBook Connect Platform

  IDBS has extended its E-WorkBook Connect cloud-based platform to include a synthetic chemistry offering.

  December 14, 2017

   · 

  1 min read
• Business

  Mayo Clinic to Begin Prospective Clinical Study With Medibio Technology for Expanded Market Opportunities

  This initial study, undertakes the prospective diagnosis and longitudinal monitoring of both unipolar and bipolar depression, along with the depressive subtypes (melancholic and atypical).

  December 14, 2017

   · 

  3 min read
• Genetown

  Proteostasis Therapeutics Prices Public Offering of Common Stock

  The gross proceeds to Proteostasis from the offering, before underwriting discounts and commissions and offering costs, are expected to be $40 million

  December 14, 2017

   · 

  4 min read